Disorder (of) --see also Disease
acantholytic
L11.9 specified NEC
L11.8 acute
psychotic
--see Psychosis, acute stress
F43.0 adjustment (grief)
F43.20 with
anxiety
F43.22 with depressed mood
F43.23 conduct disturbance
F43.24 with emotional disturbance
F43.25 depressed mood
F43.21 with anxiety
F43.23 other specified symptom
F43.29 adrenal (capsule) (gland) (medullary)
E27.9 specified NEC
E27.8 adrenogenital
E25.9 drug-induced
E25.8 iatrogenic
E25.8 idiopathic
E25.8 adult personality (and behavior)
F69 specified NEC
F68.8 affective (mood)
--see Disorder, mood aggressive, unsocialized
F91.1 alcohol-related
F10.99 with
amnestic disorder, persisting
F10.96 anxiety disorder
F10.980 dementia, persisting
F10.97 intoxication
F10.929 with delirium
F10.921 uncomplicated
F10.920 mood disorder
F10.94 other specified
F10.988 psychotic disorder
F10.959 with
delusions
F10.950 hallucinations
F10.951 sexual dysfunction
F10.981 sleep disorder
F10.982 alcohol use
mild
F10.10 with
alcohol-induced
anxiety disorder
F10.180 bipolar and related disorder
F10.14 depressive disorder
F10.14 psychotic disorder
F10.159 sexual dysfunction
F10.181 sleep disorder
F10.182 alcohol intoxication
F10.129 delirium
F10.121 in remission (early) (sustained)
F10.11 moderate or severe
F10.20 with
alcohol-induced
anxiety disorder
F10.280 bipolar and related disorder
F10.24 depressive disorder
F10.24 major neurocognitive disorder, amnestic-confabulatory type
F10.26 major neurocognitive disorder, nonamnestic-confabulatory type
F10.27 mild neurocognitive disorder
F10.288 psychotic disorder
F10.259 sexual dysfunction
F10.281 sleep disorder
F10.282 alcohol intoxication
F10.229 delirium
F10.221 in remission (early) (sustained)
F10.21 allergic
--see Allergy alveolar NEC
J84.09 amino-acid
cystathioninuria
E72.19 cystinosis
E72.04 cystinuria
E72.01 glycinuria
E72.09 homocystinuria
E72.11 metabolism --see Disturbance, metabolism, amino-acid
specified NEC
E72.89 neonatal, transitory
P74.8 renal transport NEC
E72.09 transport NEC
E72.09 amnesic, amnestic
alcohol-induced
F10.96 with dependence
F10.26 due to general medical condition (secondary to)
F04 psychoactive NEC-induced
F19.96 with
abuse
F19.16 dependence
F19.26 sedative, hypnotic or anxiolytic-induced
F13.96 with dependence
F13.26 amphetamine-type substance use
mild
F15.10 in remission (early) (sustained)
F15.11 moderate
F15.20 in remission (early) (sustained)
F15.21 severe
F15.20 in remission (early) (sustained)
F15.21 amphetamine use (or other stimulant)
mild
with
amphetamine-induced (or other stimulant)
anxiety disorder
F15.180 bipolar and related disorder
F15.14 depressive disorder
F15.14 obsessive-compulsive and related disorder
F15.188 psychotic disorder
F15.159 sexual dysfunction
F15.181 amphetamine, cocaine, or other stimulant intoxication
with perceptual disturbances
F15.122 without perceptual disturbances
F15.129 intoxication delirium
F15.121 moderate or severe
with
amphetamine-induced (or other stimulant)
anxiety disorder
F15.280 obsessive-compulsive and related disorder
F15.288 sexual dysfunction
F15.281 bipolar and related disorder
F15.24 depressive disorder
F15.24 psychotic disorder
F15.259 amphetamine, cocaine, or other stimulant intoxication
with perceptual disturbances
F15.222 without perceptual disturbances
F15.229 intoxication delirium
F15.221 anaerobic glycolysis with anemia
D55.2 anxiety
F41.9 due to (secondary to)
alcohol
F10.980 in
abuse
F10.180 dependence
F10.280 amphetamine
F15.980 in
abuse
F15.180 dependence
F15.280 anxiolytic
F13.980 in
abuse
F13.180 dependence
F13.280 caffeine
F15.980 in
abuse
F15.180 dependence
F15.280 cannabis
F12.980 in
abuse
F12.180 dependence
F12.280 cocaine
F14.980 in
abuse
F14.180 dependence
F14.180 general medical condition
F06.4 hallucinogen
F16.980 in
abuse
F16.180 dependence
F16.280 hypnotic
F13.980 in
abuse
F13.180 dependence
F13.280 inhalant
F18.980 in
abuse
F18.180 dependence
F18.280 phencyclidine
F16.980 in
abuse
F16.180 dependence
F16.280 psychoactive substance NEC
F19.980 in
abuse
F19.180 dependence
F19.280 sedative
F13.980 in
abuse
F13.180 dependence
F13.280 volatile solvents
F18.980 in
abuse
F18.180 dependence
F18.280 generalized
F41.1 illness
F45.21 mixed
with depression (mild)
F41.8 specified NEC
F41.3 organic
F06.4 phobic
F40.9 of childhood
F40.8 specified NEC
F41.8 aortic valve
--see Endocarditis, aortic aromatic amino-acid metabolism
E70.9 specified NEC
E70.8 arteriole NEC
I77.89 artery NEC
I77.89 articulation
--see Disorder, joint attachment (childhood)
disinhibited
F94.2 reactive
F94.1 attention-deficit hyperactivity (adolescent) (adult) (child)
F90.9 combined
presentation
F90.2 type
F90.2 hyperactive
impulsive presentation
F90.1 type
F90.1 inattentive
presentation
F90.0 type
F90.0 specified type NEC
F90.8 attention-deficit without hyperactivity (adolescent) (adult) (child)
F98.8 auditory processing (central)
H93.25 autistic
F84.0 autism spectrum
F84.0 autoimmune
D89.89 autonomic nervous system
G90.9 specified NEC
G90.8 avoidant
child or adolescent
F40.10 restrictive food intake
F50.82 balance
acid-base
E87.8 mixed
E87.4 electrolyte
E87.8 fluid NEC
E87.8 behavioral (disruptive)
--see Disorder, conduct beta-amino-acid metabolism
E72.89 bile acid and cholesterol metabolism
E78.70 Barth syndrome
E78.71 other specified
E78.79 Smith-Lemli-Opitz syndrome
E78.72 bilirubin excretion
E80.6 binge eating
F50.81 binocular
movement
H51.9 convergence
excess
H51.12 insufficiency
H51.11 internuclear ophthalmoplegia
--see Ophthalmoplegia, internuclear palsy of conjugate gaze
H51.0 specified type NEC
H51.8 vision NEC
--see Disorder, vision, binocular bipolar (I) (type 1)
F31.9 and related due to a known physiological condition
with
manic features
F06.33 manic- or hypomanic-like episodes
F06.33 mixed features
F06.34 current episode (or most recent)
depressed
F31.9 with psychotic features
F31.5 without psychotic features
F31.30 mild
F31.31 moderate
F31.32 severe (without psychotic features)
F31.4 with psychotic features
F31.5 hypomanic
F31.0 manic
F31.9 with psychotic features
F31.2 without psychotic features
F31.10 mild
F31.11 moderate
F31.12 severe (without psychotic features)
F31.13 with psychotic features
F31.2 mixed
F31.60 mild
F31.61 moderate
F31.62 severe (without psychotic features)
F31.63 with psychotic features
F31.64 severe depression (without psychotic features)
F31.4 with psychotic features
F31.5 in remission (currently)
F31.70 in full remission
most recent episode
depressed
F31.76 hypomanic
F31.72 manic
F31.74 mixed
F31.78 in partial remission
most recent episode
depressed
F31.75 hypomanic
F31.71 manic
F31.73 mixed
F31.77 specified NEC
F31.89 II (type 2)
F31.81 organic
F06.30 single manic episode
F30.9 mild
F30.11 moderate
F30.12 severe (without psychotic symptoms)
F30.13 with psychotic symptoms
F30.2 bladder
N32.9 functional NEC
N31.9 in schistosomiasis
B65.0 [N33] specified NEC
N32.89 bleeding
D68.9 blood
D75.9 in congenital early syphilis
A50.09 [D77] body dysmorphic
F45.22 bone
M89.9 continuity
M84.9 specified type NEC
M84.80 ankle
M84.87- fibula
M84.86- foot
M84.87- hand
M84.84- humerus
M84.82- neck
M84.88 pelvis
M84.859 radius
M84.83- rib
M84.88 shoulder
M84.81- skull
M84.88 thigh
M84.85- tibia
M84.86- ulna
M84.83- vertebra
M84.88 density and structure
M85.9 cyst --see also Cyst, bone, specified type NEC
aneurysmal
--see Cyst, bone, aneurysmal solitary
--see Cyst, bone, solitary diffuse idiopathic skeletal hyperostosis
--see Hyperostosis, ankylosing fibrous dysplasia (monostotic)
--see Dysplasia, fibrous, bone fluorosis
--see Fluorosis, skeletal hyperostosis of skull
M85.2 osteitis condensans
--see Osteitis, condensans specified type NEC
M85.8- ankle
M85.87- foot
M85.87- forearm
M85.83- hand
M85.84- lower leg
M85.86- multiple sites
M85.89 neck
M85.88 rib
M85.88 shoulder
M85.81- skull
M85.88 thigh
M85.85- upper arm
M85.82- vertebra
M85.88 development and growth NEC
M89.20 carpus
M89.24- clavicle
M89.21- femur
M89.25- fibula
M89.26- finger
M89.24- humerus
M89.22- ilium
M89.259 ischium
M89.259 metacarpus
M89.24- metatarsus
M89.27- multiple sites
M89.29 neck
M89.28 radius
M89.23- rib
M89.28 scapula
M89.21- skull
M89.28 tarsus
M89.27- tibia
M89.26- toe
M89.27- ulna
M89.23- vertebra
M89.28 specified type NEC
M89.8X- brachial plexus
G54.0 branched-chain amino-acid metabolism
E71.2 specified NEC
E71.19 breast
N64.9 agalactia
--see Agalactia associated with
lactation
O92.70 specified NEC
O92.79 pregnancy
O92.20 specified NEC
O92.29 puerperium
O92.20 specified NEC
O92.29 cracked nipple
--see Cracked nipple galactorrhea
--see Galactorrhea hypogalactia
O92.4 lactation disorder NEC
O92.79 mastitis
--see Mastitis nipple infection
--see Infection, nipple retracted nipple
--see Retraction, nipple specified type NEC
N64.89 Briquet's
F45.0 bullous, in diseases classified elsewhere
L14 caffeine use
mild
with
caffeine-induced
anxiety disorder
F15.180 sleep disorder
F15.182 moderate or severe
with
caffeine-induced
anxiety disorder
F15.280 sleep disorder
F15.282 cannabis use
mild
F12.10 with
cannabis-induced
anxiety disorder
F12.180 psychotic disorder
F12.159 sleep disorder
F12.188 cannabis intoxication delirium
F12.121 with perceptual disturbances
F12.122 without perceptual disturbances
F12.129 in remission (early) (sustained)
F12.11 moderate or severe
F12.20 with
cannabis-induced
anxiety disorder
F12.280 psychotic disorder
F12.259 sleep disorder
F12.288 cannabis intoxication
with perceptual disturbances
F12.222 without perceptual disturbances
F12.229 delirium
F12.221 in remission (early) (sustained)
F12.21 carbohydrate
absorption, intestinal NEC
E74.39 metabolism (congenital)
E74.9 specified NEC
E74.8 cardiac, functional
I51.89 carnitine metabolism
E71.40 cartilage
M94.9 articular NEC
--see Derangement, joint, articular cartilage chondrocalcinosis
--see Chondrocalcinosis specified type NEC
M94.8X- articular
--see Derangement, joint, articular cartilage multiple sites
M94.8X0 catatonia (due to known physiological condition) (with another mental disorder)
F06.1 catatonic
due to known physiological condition (secondary to)
F06.1 organic
F06.1 central auditory processing
H93.25 cervical
region NEC
M53.82 root NEC (nerve)
G54.2 character NOS
F60.9 childhood disintegrative NEC
F84.3 cholesterol and bile acid metabolism
E78.70 Barth syndrome
E78.71 other specified
E78.79 Smith-Lemli-Opitz syndrome
E78.72 choroid
H31.9 atrophy
--see Atrophy, choroid degeneration
--see Degeneration, choroid detachment
--see Detachment, choroid dystrophy
--see Dystrophy, choroid hemorrhage
--see Hemorrhage, choroid rupture
--see Rupture, choroid scar
--see Scar, chorioretinal solar retinopathy
--see Retinopathy, solar specified type NEC
H31.8 ciliary body
--see Disorder, iris degeneration
--see Degeneration, ciliary body coagulation (factor) --see also Defect, coagulation
D68.9 newborn, transient
P61.6 cocaine use
mild
F14.10 with
amphetamine, cocaine, or other stimulant intoxication
with perceptual disturbances
F14.122 without perceptual disturbances
F14.129 cocaine-induced
anxiety disorder
F14.180 bipolar and related disorder
F14.14 depressive disorder
F14.14 obsessive-compulsive and related disorder
F14.188 psychotic disorder
F14.159 sexual dysfunction
F14.181 sleep disorder
F14.182 cocaine intoxication delirium
F14.121 in remission (early) (sustained)
F14.11 moderate or severe
F14.20 with
amphetamine, cocaine, or other stimulant intoxication
with perceptual disturbances
F14.222 without perceptual disturbances
F14.229 cocaine-induced
anxiety disorder
F14.280 bipolar and related disorder
F14.24 depressive disorder
F14.24 obsessive-compulsive and related disorder
F14.288 psychotic disorder
F14.259 sexual dysfunction
F14.281 sleep disorder
F14.282 cocaine intoxication delirium
F14.221 in remission (early) (sustained)
F14.21 coccyx NEC
M53.3 cognitive
F09 due to general medical condition (secondary to)
F09 persisting
R41.89 due to
alcohol
F10.97 with dependence
F10.27 anxiolytics
F13.97 with dependence
F13.27 hypnotics
F13.97 with dependence
F13.27 sedatives
F13.97 with dependence
F13.27 specified substance NEC
F19.97 with
abuse
F19.17 dependence
F19.27 communication
F80.9 social pragmatic
F80.82 conduct (childhood)
F91.9 adjustment reaction
--see Disorder, adjustment adolescent onset type
F91.2 childhood onset type
F91.1 compulsive
F63.9 confined to family context
F91.0 depressive
F91.8 group type
F91.2 hyperkinetic --see Disorder, attention-deficit hyperactivity
oppositional defiance
F91.3 socialized
F91.2 solitary aggressive type
F91.1 specified NEC
F91.8 unsocialized (aggressive)
F91.1 conduction, heart
I45.9 congenital glycosylation (CDG)
E74.8 conjunctiva
H11.9 infection
--see Conjunctivitis connective tissue, localized
L94.9 specified NEC
L94.8 conversion (functional neurological symptom disorder)
with
abnormal movement
F44.4 anesthesia or sensory loss
F44.6 attacks or seizures
F44.5 mixed symptoms
F44.7 special sensory symptoms
F44.6 speech symptoms
F44.4 swallowing symptoms
F44.4 weakness or paralysis
F44.4 convulsive (secondary)
--see Convulsions cornea
H18.9 deformity
--see Deformity, cornea degeneration
--see Degeneration, cornea deposits
--see Deposit, cornea due to contact lens
H18.82- specified as edema
--see Edema, cornea edema
--see Edema, cornea keratitis
--see Keratitis keratoconjunctivitis
--see Keratoconjunctivitis membrane change
--see Change, corneal membrane neovascularization
--see Neovascularization, cornea scar
--see Opacity, cornea specified type NEC
H18.89- ulcer
--see Ulcer, cornea corpus cavernosum
N48.9 cranial nerve
--see Disorder, nerve, cranial cyclothymic
F34.0 defiant oppositional
F91.3 delusional (persistent) (systematized)
F22 induced
F24 depersonalization
F48.1 depressive
F32.9 due to known physiological condition
with
depressive features
F06.31 major depressive-like episode
F06.32 mixed features
F06.34 major
F32.9 with psychotic symptoms
F32.3 in remission (full)
F32.5 partial
F32.4 recurrent
F33.9 with psychotic features
F33.3 single episode
F32.9 mild
F32.0 moderate
F32.1 severe (without psychotic symptoms)
F32.2 with psychotic symptoms
F32.3 organic
F06.31 persistent
F34.1 recurrent
F33.9 current episode
mild
F33.0 moderate
F33.1 severe (without psychotic symptoms)
F33.2 with psychotic symptoms
F33.3 in remission
F33.40 full
F33.42 partial
F33.41 specified NEC
F33.8 single episode
--see Episode, depressive specified NEC
F32.89 developmental
F89 arithmetical skills
F81.2 coordination (motor)
F82 expressive writing
F81.81 language
F80.9 expressive
F80.1 mixed receptive and expressive
F80.2 receptive type
F80.2 specified NEC
F80.89 learning
F81.9 arithmetical
F81.2 reading
F81.0 mixed
F88 motor coordination or function
F82 pervasive
F84.9 specified NEC
F84.8 phonological
F80.0 reading
F81.0 scholastic skills --see also Disorder, learning
mixed
F81.89 specified NEC
F88 speech
F80.9 articulation
F80.0 specified NEC
F80.89 written expression
F81.81 diaphragm
J98.6 digestive (system)
K92.9 newborn
P78.9 specified NEC
P78.89 postprocedural
--see Complication, gastrointestinal psychogenic
F45.8 disc (intervertebral)
M51.9 with
myelopathy
cervical region
M50.00 cervicothoracic region
M50.03 high cervical region
M50.01 lumbar region
M51.06 mid-cervical region
M50.020 sacrococcygeal region
M53.3 thoracic region
M51.04 thoracolumbar region
M51.05 radiculopathy
cervical region
M50.10 cervicothoracic region
M50.13 high cervical region
M50.11 lumbar region
M51.16 lumbosacral region
M51.17 mid-cervical region
M50.120 sacrococcygeal region
M53.3 thoracic region
M51.14 thoracolumbar region
M51.15 cervical
M50.90 with
myelopathy
M50.00 C2-C3
M50.01 C3-C4
M50.01 C4-C5
M50.021 C5-C6
M50.022 C6-C7
M50.023 C7-T1
M50.03 cervicothoracic region
M50.03 high cervical region
M50.01 mid-cervical region
M50.020 neuritis, radiculitis or radiculopathy
M50.10 C2-C3
M50.11 C3-C4
M50.11 C4-C5
M50.121 C5-C6
M50.122 C6-C7
M50.123 C7-T1
M50.13 cervicothoracic region
M50.13 high cervical region
M50.11 mid-cervical region
M50.120 C2-C3
M50.91 C3-C4
M50.91 C4-C5
M50.921 C5-C6
M50.922 C6-C7
M50.923 C7-T1
M50.93 cervicothoracic region
M50.93 degeneration
M50.30 C2-C3
M50.31 C3-C4
M50.31 C4-C5
M50.321 C5-C6
M50.322 C6-C7
M50.323 C7-T1
M50.33 cervicothoracic region
M50.33 high cervical region
M50.31 mid-cervical region
M50.320 displacement
M50.20 C2-C3
M50.21 C3-C4
M50.21 C4-C5
M50.221 C5-C6
M50.222 C6-C7
M50.223 C7-T1
M50.23 cervicothoracic region
M50.23 high cervical region
M50.21 mid-cervical region
M50.220 high cervical region
M50.91 mid-cervical region
M50.920 specified type NEC
M50.80 C2-C3
M50.81 C3-C4
M50.81 C4-C5
M50.821 C5-C6
M50.822 C6-C7
M50.823 C7-T1
M50.83 cervicothoracic region
M50.83 high cervical region
M50.81 mid-cervical region
M50.820 specified NEC
lumbar region
M51.86 lumbosacral region
M51.87 sacrococcygeal region
M53.3 thoracic region
M51.84 thoracolumbar region
M51.85 disinhibited attachment (childhood)
F94.2 disintegrative, childhood NEC
F84.3 disruptive
F91.9 mood dysregulation
F34.81 specified NEC
F91.8 disruptive behavior
--see Disorder, conduct dissocial personality
F60.2 dissociative
F44.9 affecting
motor function
F44.4 and sensation
F44.7 sensation
F44.6 and motor function
F44.7 brief reactive
F43.0 due to general medical condition (secondary to)
F06.8 mixed
F44.7 organic
F06.8 other specified NEC
F44.89 double heterozygous sickling --see Disease, sickle-cell
dream anxiety
F51.5 drug induced hemorrhagic
D68.32 drug related
F19.99 abuse
--see Abuse, drug dependence
--see Dependence, drug dysmorphic body
F45.22 dysthymic
F34.1 ear
H93.9- bleeding
--see Otorrhagia deafness
--see Deafness degenerative
H93.09- discharge
--see Otorrhea external
H61.9- auditory canal stenosis
--see Stenosis, external ear canal exostosis
--see Exostosis, external ear canal impacted cerumen
--see Impaction, cerumen otitis
--see Otitis, externa perichondritis
--see Perichondritis, ear pinna
--see Disorder, pinna specified type NEC
H61.89- in diseases classified elsewhere
H62.8X- inner
H83.9- vestibular dysfunction
--see Disorder, vestibular function middle
H74.9- adhesive
H74.1- ossicle
--see Abnormal, ear ossicles polyp
--see Polyp, ear (middle) specified NEC, in diseases classified elsewhere
H75.8- postprocedural --see Complications, ear, procedure
specified NEC, in diseases classified elsewhere
H94.8- eating (adult) (psychogenic)
F50.9 anorexia
--see Anorexia binge
F50.81 bulimia
F50.2 child
F98.29 pica
F98.3 rumination disorder
F98.21 pica
F50.89 childhood
F98.3 electrolyte NEC (balance)
E87.8 with
abortion --see Abortion by type complicated by specified condition NEC
ectopic pregnancy
O08.5 molar pregnancy
O08.5 acidosis (metabolic) (respiratory)
E87.2 alkalosis (metabolic) (respiratory)
E87.3 elimination, transepidermal
L87.9 specified NEC
L87.8 emotional (persistent)
F34.9 of childhood
F93.9 specified NEC
F93.8 endocrine
E34.9 postprocedural
E89.89 specified NEC
E89.89 erectile (male) (organic) --see also Dysfunction, sexual, male, erectile
N52.9 nonorganic
F52.21 erythematous
--see Erythema esophagus
K22.9 functional
K22.4 psychogenic
F45.8 eustachian tube
H69.9- infection
--see Salpingitis, eustachian obstruction
--see Obstruction, eustachian tube patulous
--see Patulous, eustachian tube specified NEC
H69.8- exhibitionistic
F65.2 extrapyramidal
G25.9 in diseases classified elsewhere --see category G26
specified type NEC
G25.89 eye
H57.9 postprocedural
--see Complication, postprocedural, eye eyelid
H02.9 cyst
--see Cyst, eyelid degenerative
H02.70 chloasma
--see Chloasma, eyelid madarosis
--see Madarosis specified type NEC
H02.79 vitiligo
--see Vitiligo, eyelid xanthelasma
--see Xanthelasma dermatochalasis
--see Dermatochalasis edema
--see Edema, eyelid elephantiasis
--see Elephantiasis, eyelid foreign body, retained
--see Foreign body, retained, eyelid function
H02.59 abnormal innervation syndrome
--see Syndrome, abnormal innervation blepharochalasis
--see Blepharochalasis blepharoclonus
--see Blepharoclonus blepharophimosis
--see Blepharophimosis blepharoptosis
--see Blepharoptosis lagophthalmos
--see Lagophthalmos lid retraction
--see Retraction, lid hypertrichosis
--see Hypertrichosis, eyelid specified type NEC
H02.89 vascular
H02.879 left
H02.876 lower
H02.875 upper
H02.874 right
H02.873 lower
H02.872 upper
H02.871 factitious
by proxy
F68.A imposed on another
F68.A imposed on self
F68.10 with predominantly
psychological symptoms
F68.11 with physical symptoms
F68.13 physical symptoms
F68.12 with psychological symptoms
F68.13 factor, coagulation
--see Defect, coagulation fatty acid
metabolism
E71.30 specified NEC
E71.39 oxidation
LCAD
E71.310 MCAD
E71.311 SCAD
E71.312 specified deficiency NEC
E71.318 feeding (infant or child) --see also Disorder, eating
R63.3 or eating disorder
F50.9 specified NEC
F50.9 feigned (with obvious motivation)
Z76.5 without obvious motivation
--see Disorder, factitious female
hypoactive sexual desire
F52.0 orgasmic
F52.31 sexual interest/arousal
F52.22 fetishistic
F65.0 fibroblastic
M72.9 specified NEC
M72.8 fluency
adult onset
F98.5 childhood onset
F80.81 following
cerebral infarction
I69.323 cerebrovascular disease
I69.923 specified disease NEC
I69.823 intracerebral hemorrhage
I69.123 nontraumatic intracranial hemorrhage NEC
I69.223 subarachnoid hemorrhage
I69.023 in conditions classified elsewhere
R47.82 fluid balance
E87.8 follicular (skin)
L73.9 specified NEC
L73.8 frotteuristic
F65.81 fructose metabolism
E74.10 essential fructosuria
E74.11 fructokinase deficiency
E74.11 fructose-1, 6-diphosphatase deficiency
E74.19 hereditary fructose intolerance
E74.12 other specified
E74.19 functional polymorphonuclear neutrophils
D71 gallbladder, biliary tract and pancreas in diseases classified elsewhere
K87 gambling
F63.0 gamma aminobutyric acid metabolism (GABA)
E72.81 gamma-glutamyl cycle
E72.89 gastric (functional)
K31.9 motility
K30 psychogenic
F45.8 secretion
K30 gastrointestinal NOS (functional)
K92.9 newborn
P78.9 psychogenic
F45.8 gender-identity or -role
F64.9 childhood
F64.2 effect on relationship
F66 of adolescence or adulthood
F64.0 nontranssexual
F64.8 specified NEC
F64.8 uncertainty
F66 genito-pelvic pain penetration
F52.6 genitourinary system
female
N94.9 male
N50.9 psychogenic
F45.8 globe
H44.9 degenerated condition
H44.50 absolute glaucoma
H44.51- atrophy
H44.52- leucocoria
H44.53- degenerative
H44.30 chalcosis
H44.31- myopia --see also Myopia, degenerative
H44.2- siderosis
H44.32- specified type NEC
H44.39- endophthalmitis
--see Endophthalmitis foreign body, retained
--see Foreign body, intraocular, old, retained hemophthalmos
--see Hemophthalmos hypotony
H44.40 due to
ocular fistula
H44.42- specified disorder NEC
H44.43- flat anterior chamber
H44.41- primary
H44.44- luxation
--see Luxation, globe specified type NEC
H44.89 glomerular (in)
N05.9 amyloidosis
E85.4 [N08] cryoglobulinemia
D89.1 [N08] disseminated intravascular coagulation
D65 [N08] Fabry's disease
E75.21 [N08] familial lecithin cholesterol acyltransferase deficiency
E78.6 [N08] Goodpasture's syndrome
M31.0 hemolytic-uremic syndrome
D59.3 Henoch purpura (-Schönlein)
D69.0 [N08] malariae malaria
B52.0 microscopic polyangiitis
M31.7 [N08] multiple myeloma
C90.0- [N08] mumps
B26.83 schistosomiasis
B65.9 [N08] sepsis NEC
A41.- [N08] streptococcal
A40.- [N08] sickle-cell disorders
D57.- [N08] strongyloidiasis
B78.9 [N08] subacute bacterial endocarditis
I33.0 [N08] syphilis
A52.75 systemic lupus erythematosus
M32.14 thrombotic thrombocytopenic purpura
M31.1 [N08] Waldenström macroglobulinemia
C88.0 [N08] Wegener's granulomatosis
M31.31 gluconeogenesis
E74.4 glucosaminoglycan metabolism
--see Disorder, metabolism, glucosaminoglycan glycine metabolism
E72.50 d-glycericacidemia
E72.59 hyperhydroxyprolinemia
E72.59 hyperoxaluria
R82.992 primary
E72.53 hyperprolinemia
E72.59 non-ketotic hyperglycinemia
E72.51 oxalosis
E72.53 oxaluria
E72.53 sarcosinemia
E72.59 trimethylaminuria
E72.52 glycoprotein metabolism
E77.9 specified NEC
E77.8 habit (and impulse)
F63.9 involving sexual behavior NEC
F65.9 specified NEC
F63.89 hallucinogen use
mild
F16.10 with
hallucinogen-induced
anxiety disorder
F16.180 bipolar and related disorder
F16.14 depressive disorder
F16.14 psychotic disorder
F16.159 hallucinogen intoxication delirium
F16.121 other hallucinogen intoxication
F16.129 in remission (early) (sustained)
F16.11 moderate or severe
F16.20 with
hallucinogen-induced
anxiety disorder
F16.280 bipolar and related disorder
F16.24 depressive disorder
F16.24 psychotic disorder
F16.259 hallucinogen intoxication delirium
F16.221 other hallucinogen intoxication
F16.229 in remission (early) (sustained)
F16.21 heart action
I49.9 hematological
D75.9 newborn (transient)
P61.9 specified NEC
P61.8 hematopoietic organs
D75.9 hemorrhagic NEC
D69.9 drug-induced
D68.32 due to
extrinsic circulating anticoagulants
D68.32 increase in
anti-IIa
D68.32 anti-Xa
D68.32 intrinsic
circulating anticoagulants
D68.318 increase in
antithrombin
D68.318 anti-VIIIa
D68.318 anti-IXa
D68.318 anti-XIa
D68.318 following childbirth
O72.3 hemostasis
--see Defect, coagulation histidine metabolism
E70.40 histidinemia
E70.41 other specified
E70.49 hoarding
F42.3 hyperkinetic --see Disorder, attention-deficit hyperactivity
hyperleucine-isoleucinemia
E71.19 hypervalinemia
E71.19 hypoactive sexual desire
F52.0 hypochondriacal
F45.20 body dysmorphic
F45.22 neurosis
F45.21 other specified
F45.29 identity
dissociative
F44.81 of childhood
F93.8 illness anxiety
F45.21 immune mechanism (immunity)
D89.9 specified type NEC
D89.89 impaired renal tubular function
N25.9 specified NEC
N25.89 impulse (control)
F63.9 inflammatory
pelvic, in diseases classified elsewhere --see category N74
penis
N48.29 abscess
N48.21 cellulitis
N48.22 inhalant use
mild
F18.10 with
inhalant-induced
anxiety disorder
F18.180 depressive disorder
F18.14 major neurocognitive disorder
F18.17 mild neurocognitive disorder
F18.188 psychotic disorder
F18.159 inhalant intoxication
F18.129 inhalant intoxication delirium
F18.121 in remission (early) (sustained)
F18.11 moderate or severe
F18.20 with
inhalant-induced
anxiety disorder
F18.280 depressive disorder
F18.24 major neurocognitive disorder
F18.27 mild neurocognitive disorder
F18.288 psychotic disorder
F18.259 inhalant intoxication
F18.229 inhalant intoxication delirium
F18.221 in remission (early) (sustained)
F18.21 integument, newborn
P83.9 specified NEC
P83.88 intermittent explosive
F63.81 internal secretion pancreas
--see Increased, secretion, pancreas, endocrine intestine, intestinal
carbohydrate absorption NEC
E74.39 postoperative
K91.2 functional NEC
K59.9 postoperative
K91.89 psychogenic
F45.8 vascular
K55.9 chronic
K55.1 specified NEC
K55.8 intraoperative (intraprocedural) --see Complications, intraoperative
involuntary emotional expression (IEED)
F48.2 iris
H21.9 adhesions
--see Adhesions, iris atrophy
--see Atrophy, iris chamber angle recession
--see Recession, chamber angle cyst
--see Cyst, iris degeneration
--see Degeneration, iris in diseases classified elsewhere
H22 iridodialysis
--see Iridodialysis iridoschisis
--see Iridoschisis miotic pupillary cyst
--see Cyst, pupillary pupillary
abnormality
--see Abnormality, pupillary membrane
--see Membrane, pupillary specified type NEC
H21.89 vascular NEC
H21.1X- iron metabolism
E83.10 specified NEC
E83.19 isovaleric acidemia
E71.110 jaw, developmental
M27.0 temporomandibular --see also Anomaly, dentofacial, temporomandibular joint
M26.60- joint
M25.9 derangement
--see Derangement, joint effusion
--see Effusion, joint fistula
--see Fistula, joint hemarthrosis
--see Hemarthrosis instability
--see Instability, joint osteophyte
--see Osteophyte pain
--see Pain, joint psychogenic
F45.8 specified type NEC
M25.80 ankle
M25.87- elbow
M25.82- foot joint
M25.87- hand joint
M25.84- hip
M25.85- knee
M25.86- shoulder
M25.81- wrist
M25.83- stiffness
--see Stiffness, joint ketone metabolism
E71.32 kidney
N28.9 functional (tubular)
N25.9 in
schistosomiasis
B65.9 [N29] tubular function
N25.9 specified NEC
N25.89 lacrimal system
H04.9 changes
H04.69 fistula
--see Fistula, lacrimal gland
H04.19 atrophy
--see Atrophy, lacrimal gland cyst
--see Cyst, lacrimal, gland dacryops
--see Dacryops dislocation
--see Dislocation, lacrimal gland dry eye syndrome
--see Syndrome, dry eye infection
--see Dacryoadenitis granuloma
--see Granuloma, lacrimal inflammation
--see Inflammation, lacrimal obstruction
--see Obstruction, lacrimal specified NEC
H04.89 lactation NEC
O92.79 language (developmental)
F80.9 expressive
F80.1 mixed receptive and expressive
F80.2 receptive
F80.2 late luteal phase dysphoric
N94.89 learning (specific)
F81.9 acalculia
R48.8 alexia
R48.0 mathematics
F81.2 reading
F81.0 specified
with impairment in
mathematics
F81.2 reading
F81.0 written expression
F81.81 specified NEC
F81.89 spelling
F81.81 written expression
F81.81 lens
H27.9 aphakia
--see Aphakia cataract
--see Cataract dislocation
--see Dislocation, lens specified type NEC
H27.8 ligament
M24.20 ankle
M24.27- attachment, spine
--see Enthesopathy, spinal elbow
M24.22- foot joint
M24.27- hand joint
M24.24- hip
M24.25- knee
--see Derangement, knee, specified NEC shoulder
M24.21- vertebra
M24.28 wrist
M24.23- ligamentous attachments --see also Enthesopathy
spine
--see Enthesopathy, spinal lipid
metabolism, congenital
E78.9 storage
E75.6 specified NEC
E75.5 lipoprotein
deficiency (familial)
E78.6 metabolism
E78.9 specified NEC
E78.89 liver
K76.9 malarial
B54 [K77] low back --see also Dorsopathy, specified NEC
lumbosacral
plexus
G54.1 root NEC (nerve)
G54.4 lung, interstitial, drug-induced
J70.4 acute
J70.2 chronic
J70.3 lymphoproliferative, post-transplant (PTLD)
D47.Z1 lysine and hydroxylysine metabolism
E72.3 major neurocognitive
--see Dementia, in (due to) male
erectile (organic) --see also Dysfunction, sexual, male, erectile
N52.9 nonorganic
F52.21 hypoactive sexual desire
F52.0 orgasmic
F52.32 manic
F30.9 organic
F06.33 mast cell activation
--see Activation, mast cell mastoid --see also Disorder, ear, middle
postprocedural --see Complications, ear, procedure
meniscus
--see Derangement, knee, meniscus menopausal
N95.9 specified NEC
N95.8 menstrual
N92.6 psychogenic
F45.8 specified NEC
N92.5 mental (or behavioral) (nonpsychotic)
F99 due to (secondary to)
amphetamine
due to drug abuse
--see Abuse, drug, stimulant due to drug dependence
--see Dependence, drug, stimulant brain disease, damage and dysfunction
F09 caffeine use
due to drug abuse
--see Abuse, drug, stimulant due to drug dependence
--see Dependence, drug, stimulant cannabis use
due to drug abuse
--see Abuse, drug, cannabis due to drug dependence
--see Dependence, drug, cannabis general medical condition
F09 sedative or hypnotic use
due to drug abuse
--see Abuse, drug, sedative due to drug dependence
--see Dependence, drug, sedative tobacco use (nicotine)
--see Dependence, drug, nicotine following organic brain damage
F07.9 frontal lobe syndrome
F07.0 personality change
F07.0 postconcussional syndrome
F07.81 specified NEC
F07.89 infancy, childhood or adolescence
F98.9 neurotic
--see Neurosis organic or symptomatic
F09 presenile, psychotic
F03 problem NEC
psychoneurotic
--see Neurosis psychotic
--see Psychosis puerperal
F53.0 senile, psychotic NEC
F03 metabolic, amino acid, transitory, newborn
P74.8 metabolism NOS
E88.9 amino-acid
E72.9 aromatic
E70.9 albinism
--see Albinism histidine
E70.40 histidinemia
E70.41 other specified
E70.49 hyperphenylalaninemia
E70.1 classical phenylketonuria
E70.0 other specified
E70.8 tryptophan
E70.5 tyrosine
E70.20 hypertyrosinemia
E70.21 other specified
E70.29 branched chain
E71.2 3-methylglutaconic aciduria
E71.111 hyperleucine-isoleucinemia
E71.19 hypervalinemia
E71.19 isovaleric acidemia
E71.110 maple syrup urine disease
E71.0 methylmalonic acidemia
E71.120 organic aciduria NEC
E71.118 other specified
E71.19 proprionate NEC
E71.128 proprionic acidemia
E71.121 glycine
E72.50 d-glycericacidemia
E72.59 hyperhydroxyprolinemia
E72.59 hyperoxaluria
R82.992 primary
E72.53 hyperprolinemia
E72.59 non-ketotic hyperglycinemia
E72.51 other specified
E72.59 sarcosinemia
E72.59 trimethylaminuria
E72.52 hydroxylysine
E72.3 lysine
E72.3 ornithine
E72.4 other specified
E72.89 beta-amino acid
E72.89 gamma-glutamyl cycle
E72.89 straight-chain
E72.89 sulfur-bearing
E72.10 homocystinuria
E72.11 methylenetetrahydrofolate reductase deficiency
E72.12 other specified
E72.19 bile acid and cholesterol metabolism
E78.70 bilirubin
E80.7 specified NEC
E80.6 calcium
E83.50 hypercalcemia
E83.52 hypocalcemia
E83.51 other specified
E83.59 carbohydrate
E74.9 specified NEC
E74.8 cholesterol and bile acid metabolism
E78.70 congenital
E88.9 copper
E83.00 Wilson's disease
E83.01 specified type NEC
E83.09 cystinuria
E72.01 fructose
E74.10 galactose
E74.20 glucosaminoglycan
E76.9 mucopolysaccharidosis
--see Mucopolysaccharidosis specified NEC
E76.8 glutamine
E72.89 glycine
E72.50 glycogen storage (hepatorenal)
E74.09 glycoprotein
E77.9 specified NEC
E77.8 glycosaminoglycan
E76.9 specified NEC
E76.8 in labor and delivery
O75.89 iron
E83.10 isoleucine
E71.19 leucine
E71.19 lipoid
E78.9 lipoprotein
E78.9 specified NEC
E78.89 magnesium
E83.40 hypermagnesemia
E83.41 hypomagnesemia
E83.42 other specified
E83.49 mineral
E83.9 specified NEC
E83.89 mitochondrial
E88.40 MELAS syndrome
E88.41 MERRF syndrome (myoclonic epilepsy associated with ragged-red fibers)
E88.42 other specified
E88.49 ornithine
E72.4 phosphatases
E83.30 phosphorus
E83.30 acid phosphatase deficiency
E83.39 hypophosphatasia
E83.39 hypophosphatemia
E83.39 familial
E83.31 other specified
E83.39 pseudovitamin D deficiency
E83.32 plasma protein NEC
E88.09 porphyrin
--see Porphyria postprocedural
E89.89 specified NEC
E89.89 purine
E79.9 specified NEC
E79.8 pyrimidine
E79.9 specified NEC
E79.8 pyruvate
E74.4 serine
E72.89 sodium
E87.8 specified NEC
E88.89 threonine
E72.89 valine
E71.19 zinc
E83.2 methylmalonic acidemia
E71.120 micturition NEC --see also Difficulty, micturition
R39.198 feeling of incomplete emptying
R39.14 hesitancy
R39.11 poor stream
R39.12 psychogenic
F45.8 split stream
R39.13 straining
R39.16 urgency
R39.15 mild neurocognitive
G31.84 mitochondrial metabolism
E88.40 mitral (valve)
--see Endocarditis, mitral mixed
anxiety and depressive
F41.8 of scholastic skills (developmental)
F81.89 receptive expressive language
F80.2 mood
F39 bipolar
--see Disorder, bipolar depressive
--see Disorder, depressive due to (secondary to)
alcohol
F10.94 amphetamine
F15.94 in
abuse
F15.14 dependence
F15.24 anxiolytic
F13.94 in
abuse
F13.14 dependence
F13.24 cocaine
F14.94 in
abuse
F14.14 dependence
F14.24 general medical condition
F06.30 hallucinogen
F16.94 in
abuse
F16.14 dependence
F16.24 hypnotic
F13.94 in
abuse
F13.14 dependence
F13.24 inhalant
F18.94 in
abuse
F18.14 dependence
F18.24 opioid
F11.94 in
abuse
F11.14 dependence
F11.24 phencyclidine (PCP)
F16.94 in
abuse
F16.14 dependence
F16.24 physiological condition
F06.30 with
depressive features
F06.31 major depressive-like episode
F06.32 manic features
F06.33 mixed features
F06.34 psychoactive substance NEC
F19.94 in
abuse
F19.14 dependence
F19.24 sedative
F13.94 in
abuse
F13.14 dependence
F13.24 volatile solvents
F18.94 in
abuse
F18.14 dependence
F18.24 manic episode
F30.9 with psychotic symptoms
F30.2 in remission (full)
F30.4 partial
F30.3 specified type NEC
F30.8 without psychotic symptoms
F30.10 mild
F30.11 moderate
F30.12 severe
F30.13 organic
F06.30 right hemisphere
F07.89 persistent
F34.9 cyclothymia
F34.0 dysthymia
F34.1 specified type NEC
F34.89 recurrent
F39 right hemisphere organic
F07.89 movement
G25.9 drug-induced
G25.70 akathisia
G25.71 specified NEC
G25.79 hysterical
F44.4 in diseases classified elsewhere --see category G26
periodic limb
G47.61 sleep related
G47.61 specified NEC
G25.89 sleep related NEC
G47.69 stereotyped
F98.4 treatment-induced
G25.9 multiple personality
F44.81 muscle
M62.9 attachment, spine
--see Enthesopathy, spinal in trichinellosis
--see Trichinellosis, with muscle disorder psychogenic
F45.8 specified type NEC
M62.89 tone, newborn
P94.9 specified NEC
P94.8 muscular
attachments --see also Enthesopathy
spine
--see Enthesopathy, spinal urethra
N36.44 musculoskeletal system, soft tissue
--see Disorder, soft tissue postprocedural
M96.89 psychogenic
F45.8 myoneural
G70.9 due to lead
G70.1 specified NEC
G70.89 toxic
G70.1 myotonic NEC
G71.19 nail, in diseases classified elsewhere
L62 neck region NEC
--see Dorsopathy, specified NEC neonatal onset multisystemic inflammatory (NOMID)
M04.2 nerve
G58.9 abducent NEC
--see Strabismus, paralytic, sixth nerve accessory
G52.8 acoustic --see subcategory H93.3
auditory --see subcategory H93.3
auriculotemporal
G50.8 axillary
G54.0 cerebral
--see Disorder, nerve, cranial cranial
G52.9 eighth --see subcategory H93.3
eleventh
G52.8 fifth
G50.9 first
G52.0 fourth NEC
--see Strabismus, paralytic, fourth nerve multiple
G52.7 ninth
G52.1 second NEC
--see Disorder, nerve, optic seventh NEC
G51.8 sixth NEC
--see Strabismus, paralytic, sixth nerve specified NEC
G52.8 tenth
G52.2 third NEC
--see Strabismus, paralytic, third nerve twelfth
G52.3 entrapment
--see Neuropathy, entrapment facial
G51.9 specified NEC
G51.8 femoral
--see Lesion, nerve, femoral glossopharyngeal NEC
G52.1 hypoglossal
G52.3 intercostal
G58.0 lateral
cutaneous of thigh
--see Mononeuropathy, lower limb, meralgia paresthetica popliteal
--see Lesion, nerve, popliteal lower limb
--see Mononeuropathy, lower limb medial popliteal
--see Lesion, nerve, popliteal, medial median NEC
--see Lesion, nerve, median multiple
G58.7 oculomotor NEC
--see Strabismus, paralytic, third nerve olfactory
G52.0 optic NEC
H47.09- hemorrhage into sheath
--see Hemorrhage, optic nerve ischemic
H47.01- peroneal
--see Lesion, nerve, popliteal phrenic
G58.8 plantar
--see Lesion, nerve, plantar pneumogastric
G52.2 posterior tibial
--see Syndrome, tarsal tunnel radial
--see Lesion, nerve, radial recurrent laryngeal
G52.2 root
G54.9 cervical
G54.2 lumbosacral
G54.1 specified NEC
G54.8 thoracic
G54.3 sciatic NEC
--see Lesion, nerve, sciatic specified NEC
G58.8 lower limb
--see Mononeuropathy, lower limb, specified NEC upper limb
--see Mononeuropathy, upper limb, specified NEC sympathetic
G90.9 tibial
--see Lesion, nerve, popliteal, medial trigeminal
G50.9 specified NEC
G50.8 trochlear NEC
--see Strabismus, paralytic, fourth nerve ulnar
--see Lesion, nerve, ulnar upper limb
--see Mononeuropathy, upper limb vagus
G52.2 nervous system
G98.8 autonomic (peripheral)
G90.9 specified NEC
G90.8 central
G96.9 specified NEC
G96.8 parasympathetic
G90.9 specified NEC
G98.8 sympathetic
G90.9 vegetative
G90.9 neurocognitive
R41.9 major
with
aggressive behavior
F01.51 combative behavior
F01.51 violent behavior
F01.51 due to vascular disease, with behavioral disturbance
F01.51 in (due to) (other diseases classified elsewhere) --see also Dementia, in (due to)
F02.80 with
aggressive behavior
F02.81 combative behavior
F02.81 violent behavior
F02.81 without behavioral disturbance
F01.50 mild
G31.84 neurodevelopmental
F89 specified NEC
F88 neurohypophysis NEC
E23.3 neurological NEC
R29.818 neuromuscular
G70.9 hereditary NEC
G71.9 specified NEC
G70.89 toxic
G70.1 neurotic
F48.9 specified NEC
F48.8 neutrophil, polymorphonuclear
D71 nicotine use
--see Dependence, drug, nicotine nightmare
F51.5 non-rapid eye movement sleep arousal
sleep terror type
F51.4 sleepwalking type
F51.3 nose
J34.9 specified NEC
J34.89 obsessive-compulsive
F42.9 and related disorder due to a known physiological condition
F06.8 odontogenesis NOS
K00.9 opioid use
with
opioid-induced psychotic disorder
F11.959 with
delusions
F11.950 hallucinations
F11.951 due to drug abuse
--see Abuse, drug, opioid due to drug dependence
--see Dependence, drug, opioid mild
F11.10 with
opioid-induced
anxiety disorder
F11.188 depressive disorder
F11.14 sexual dysfunction
F11.181 opioid intoxication
with perceptual disturbances
F11.122 delirium
F11.121 without perceptual disturbances
F11.129 in remission (early) (sustained)
F11.11 moderate or severe
F11.20 with
opioid-induced
anxiety disorder
F11.288 anxiety disorder
F11.988 depressive disorder
F11.24 depressive disorder
F11.94 sexual dysfunction
F11.281 sexual dysfunction
F11.981 opioid intoxication
with perceptual disturbances
F11.222 delirium
F11.221 without perceptual disturbances
F11.229 in remission (early) (sustained)
F11.21 oppositional defiant
F91.3 optic
chiasm
H47.49 due to
inflammatory disorder
H47.41 neoplasm
H47.42 vascular disorder
H47.43 disc
H47.39- coloboma
--see Coloboma, optic disc drusen
--see Drusen, optic disc pseudopapilledema
--see Pseudopapilledema radiations
--see Disorder, visual, pathway tracts
--see Disorder, visual, pathway orbit
H05.9 cyst
--see Cyst, orbit deformity
--see Deformity, orbit edema
--see Edema, orbit enophthalmos
--see Enophthalmos exophthalmos
--see Exophthalmos hemorrhage
--see Hemorrhage, orbit inflammation
--see Inflammation, orbit myopathy
--see Myopathy, extraocular muscles retained foreign body
--see Foreign body, orbit, old specified type NEC
H05.89 organic
anxiety
F06.4 catatonic
F06.1 delusional
F06.2 dissociative
F06.8 emotionally labile (asthenic)
F06.8 mood (affective)
F06.30 schizophrenia-like
F06.2 orgasmic (female)
F52.31 male
F52.32 ornithine metabolism
E72.4 overanxious
F41.1 of childhood
F93.8 pain
with related psychological factors
F45.42 exclusively related to psychological factors
F45.41 genito-pelvic penetration disorder
F52.6 pancreatic internal secretion
E16.9 specified NEC
E16.8 panic
F41.0 with agoraphobia
F40.01 papulosquamous
L44.9 in diseases classified elsewhere
L45 specified NEC
L44.8 paranoid
F22 induced
F24 shared
F24 paraphilic
F65.9 specified NEC
F65.89 parathyroid (gland)
E21.5 specified NEC
E21.4 parietoalveolar NEC
J84.09 paroxysmal, mixed
R56.9 patella
M22.9- chondromalacia
--see Chondromalacia, patella derangement NEC
M22.3X- recurrent
dislocation
--see Dislocation, patella, recurrent subluxation
--see Dislocation, patella, recurrent, incomplete specified NEC
M22.8X- patellofemoral
M22.2X- pedophilic
F65.4 pentose phosphate pathway with anemia
D55.1 perception, due to hallucinogens
F16.983 in
abuse
F16.183 dependence
F16.283 peripheral nervous system NEC
G64 peroxisomal
E71.50 biogenesis
neonatal adrenoleukodystrophy
E71.511 specified disorder NEC
E71.518 Zellweger syndrome
E71.510 rhizomelic chondrodysplasia punctata
E71.540 specified form NEC
E71.548 group 1
E71.518 group 2
E71.53 group 3
E71.542 X-linked adrenoleukodystrophy
E71.529 adolescent
E71.521 adrenomyeloneuropathy
E71.522 childhood
E71.520 specified form NEC
E71.528 Zellweger-like syndrome
E71.541 persistent
pain (somatoform)
F45.41 affective (mood)
F34.9 personality --see also Personality
F60.9 affective
F34.0 aggressive
F60.3 amoral
F60.2 anankastic
F60.5 antisocial
F60.2 anxious
F60.6 asocial
F60.2 asthenic
F60.7 avoidant
F60.6 borderline
F60.3 change due to general medical condition (secondary)
F07.0 compulsive
F60.5 cyclothymic
F34.0 dependent (passive)
F60.7 depressive
F34.1 dissocial
F60.2 emotional instability
F60.3 expansive paranoid
F60.0 explosive
F60.3 following organic brain damage
F07.9 histrionic
F60.4 hyperthymic
F34.0 hypothymic
F34.1 hysterical
F60.4 immature
F60.89 inadequate
F60.7 labile
F60.3 mixed (nonspecific)
F60.89 moral deficiency
F60.2 narcissistic
F60.81 negativistic
F60.89 obsessional
F60.5 obsessive (-compulsive)
F60.5 organic
F07.9 overconscientious
F60.5 paranoid
F60.0 passive (-dependent)
F60.7 passive-aggressive
F60.89 pathological NEC
F60.9 pseudosocial
F60.2 psychopathic
F60.2 schizoid
F60.1 schizotypal
F21 self-defeating
F60.7 specified NEC
F60.89 type A
F60.5 unstable (emotional)
F60.3 pervasive, developmental
F84.9 phencyclidine use
mild
F16.10 with
phencyclidine-induced
anxiety disorder
F16.180 bipolar and related disorder
F16.14 depressive disorder
F16.14 psychotic disorder
F16.159 phencyclidine intoxication
F16.129 phencyclidine intoxication delirium
F16.121 in remission (early) (sustained)
F16.11 moderate or severe
F16.20 with
phencyclidine-induced
anxiety disorder
F16.280 bipolar and related disorder
F16.24 depressive disorder
F16.24 psychotic disorder
F16.259 phencyclidine intoxication
F16.229 phencyclidine intoxication delirium
F16.221 in remission (early) (sustained)
F16.21 phobic anxiety, childhood
F40.8 phosphate-losing tubular
N25.0 pigmentation
L81.9 choroid, congenital
Q14.3 diminished melanin formation
L81.6 iron
L81.8 specified NEC
L81.8 pinna (noninfective)
H61.10- deformity, acquired
H61.11- hematoma
H61.12- perichondritis
--see Perichondritis, ear specified type NEC
H61.19- pituitary gland
E23.7 iatrogenic (postprocedural)
E89.3 specified NEC
E23.6 platelets
D69.1 plexus
G54.9 specified NEC
G54.8 polymorphonuclear neutrophils
D71 porphyrin metabolism
--see Porphyria postconcussional
F07.81 posthallucinogen perception
F16.983 in
abuse
F16.183 dependence
F16.283 postmenopausal
N95.9 specified NEC
N95.8 postprocedural (postoperative) --see Complications, postprocedural
post-transplant lymphoproliferative
D47.Z1 post-traumatic stress (PTSD)
F43.10 acute
F43.11 chronic
F43.12 premenstrual dysphoric (PMDD)
F32.81 prepuce
N47.8 propionic acidemia
E71.121 prostate
N42.9 specified NEC
N42.89 psychogenic NOS --see also condition
F45.9 anxiety
F41.8 appetite
F50.9 asthenic
F48.8 cardiovascular (system)
F45.8 compulsive
F42.8 cutaneous
F54 depressive
F32.9 digestive (system)
F45.8 dysmenorrheic
F45.8 dyspneic
F45.8 endocrine (system)
F54 eye NEC
F45.8 feeding
--see Disorder, eating functional NEC
F45.8 gastric
F45.8 gastrointestinal (system)
F45.8 genitourinary (system)
F45.8 heart (function) (rhythm)
F45.8 hyperventilatory
F45.8 hypochondriacal
--see Disorder, hypochondriacal intestinal
F45.8 joint
F45.8 learning
F81.9 limb
F45.8 lymphatic (system)
F45.8 menstrual
F45.8 micturition
F45.8 monoplegic NEC
F44.4 motor
F44.4 muscle
F45.8 musculoskeletal
F45.8 neurocirculatory
F45.8 obsessive
F42.8 occupational
F48.8 organ or part of body NEC
F45.8 paralytic NEC
F44.4 phobic
F40.9 physical NEC
F45.8 rectal
F45.8 respiratory (system)
F45.8 rheumatic
F45.8 sexual (function)
F52.9 skin (allergic) (eczematous)
F54 sleep
F51.9 specified part of body NEC
F45.8 stomach
F45.8 psychological
F99 associated with
disease classified elsewhere
F54 sexual
development
F66 relationship
F66 uncertainty about gender identity
F64.9 psychomotor NEC
F44.4 hysterical
F44.4 psychoneurotic --see also Neurosis
mixed NEC
F48.8 psychophysiologic
--see Disorder, somatoform psychosexual
F65.9 development
F66 identity of childhood
F64.2 psychosomatic NOS
--see Disorder, somatoform multiple
F45.0 undifferentiated
F45.1 psychotic
--see Psychosis transient (acute)
F23 puberty
E30.9 specified NEC
E30.8 pulmonary (valve)
--see Endocarditis, pulmonary purine metabolism
E79.9 pyrimidine metabolism
E79.9 pyruvate metabolism
E74.4 reactive attachment (childhood)
F94.1 reading
R48.0 developmental (specific)
F81.0 receptive language
F80.2 receptor, hormonal, peripheral --see also Syndrome, androgen insensitivity
E34.50 recurrent brief depressive
F33.8 reflex
R29.2 refraction
H52.7 aniseikonia
H52.32 anisometropia
H52.31 astigmatism
--see Astigmatism hypermetropia
--see Hypermetropia myopia
--see Myopia presbyopia
H52.4 specified NEC
H52.6 relationship
F68.8 due to sexual orientation
F66 REM sleep behavior
G47.52 renal function, impaired (tubular)
N25.9 resonance
R49.9 specified NEC
R49.8 respiratory function, impaired --see also Failure, respiration
postprocedural
--see Complication, postoperative, respiratory system psychogenic
F45.8 retina
H35.9 angioid streaks
H35.33 changes in vascular appearance
H35.01- degeneration
--see Degeneration, retina dystrophy (hereditary)
--see Dystrophy, retina edema
H35.81 hemorrhage
--see Hemorrhage, retina ischemia
H35.82 macular degeneration
--see Degeneration, macula microaneurysms
H35.04- microvascular abnormality NEC
H35.09 neovascularization
--see Neovascularization, retina retinopathy
--see Retinopathy separation of layers
H35.70 central serous chorioretinopathy
H35.71- pigment epithelium detachment (serous)
H35.72- hemorrhagic
H35.73- specified type NEC
H35.89 telangiectasis
--see Telangiectasis, retina vasculitis
--see Vasculitis, retina retroperitoneal
K68.9 right hemisphere organic affective
F07.89 rumination (infant or child)
F98.21 sacrum, sacrococcygeal NEC
M53.3 schizoaffective
F25.9 bipolar type
F25.0 depressive type
F25.1 manic type
F25.0 mixed type
F25.0 specified NEC
F25.8 schizoid of childhood
F84.5 schizophrenia spectrum and other psychotic disorder
F29 specified NEC
F28 schizophreniform
F20.81 brief
F23 schizotypal (personality)
F21 secretion, thyrocalcitonin
E07.0 sedative, hypnotic, or anxiolytic use
mild
F13.10 with
sedative, hypnotic, or anxiolytic-induced
anxiety disorder
F13.180 bipolar and related disorder
F13.14 depressive disorder
F13.14 psychotic disorder
F13.159 sexual dysfunction
F13.181 sedative, hypnotic, or anxiolytic intoxication
F13.129 sedative, hypnotic, or anxiolytic intoxication delirium
F13.121 in remission (early) (sustained)
F13.11 moderate or severe
F13.20 with
sedative, hypnotic, or anxiolytic-induced
anxiety disorder
F13.280 bipolar and related disorder
F13.24 depressive disorder
F13.24 major neurocognitive disorder
F13.27 mild neurocognitive disorder
F13.288 psychotic disorder
F13.259 sexual dysfunction
F13.281 sedative, hypnotic, or anxiolytic intoxication
F13.229 sedative, hypnotic, or anxiolytic intoxication delirium
F13.221 in remission (early) (sustained)
F13.21 seizure --see also Epilepsy
G40.909 intractable
G40.919 with status epilepticus
G40.911 semantic pragmatic
F80.89 with autism
F84.0 sense of smell
R43.1 psychogenic
F45.8 separation anxiety, of childhood
F93.0 sexual
arousal, female
F52.22 aversion
F52.1 function, psychogenic
F52.9 interest/arousal, female
F52.22 masochism
F65.51 maturation
F66 nonorganic
F52.9 preference --see also Deviation, sexual
F65.9 fetishistic transvestism
F65.1 relationship
F66 sadism
F65.52 shyness, of childhood and adolescence
F40.10 sibling rivalry
F93.8 sickle-cell (sickling) (homozygous) --see Disease, sickle-cell
heterozygous
D57.3 specified type NEC
D57.8- trait
D57.3 sinus (nasal)
J34.9 specified NEC
J34.89 skin
L98.9 atrophic
L90.9 specified NEC
L90.8 granulomatous
L92.9 specified NEC
L92.8 hypertrophic
L91.9 specified NEC
L91.8 infiltrative NEC
L98.6 newborn
P83.9 specified NEC
P83.88 picking
F42.4 psychogenic (allergic) (eczematous)
F54 sleep
G47.9 breathing-related
--see Apnea, sleep circadian rhythm
G47.20 advance sleep phase type
G47.22 delayed sleep phase type
G47.21 due to
alcohol
abuse
F10.182 dependence
F10.282 use
F10.982 amphetamines
abuse
F15.182 dependence
F15.282 use
F15.982 caffeine
abuse
F15.182 dependence
F15.282 use
F15.982 cocaine
abuse
F14.182 dependence
F14.282 use
F14.982 drug NEC
abuse
F19.182 dependence
F19.282 use
F19.982 opioid
abuse
F11.182 dependence
F11.282 use
F11.982 psychoactive substance NEC
abuse
F19.182 dependence
F19.282 use
F19.982 sedative, hypnotic, or anxiolytic
abuse
F13.182 dependence
F13.282 use
F13.982 stimulant NEC
abuse
F15.182 dependence
F15.282 use
F15.982 free running type
G47.24 in conditions classified elsewhere
G47.27 irregular sleep wake type
G47.23 jet lag type
G47.25 non-24-hour sleep-wake type
G47.24 shift work type
G47.26 specified NEC
G47.29 due to
alcohol
abuse
F10.182 dependence
F10.282 use
F10.982 amphetamine
abuse
F15.182 dependence
F15.282 use
F15.982 anxiolytic
abuse
F13.182 dependence
F13.282 use
F13.982 caffeine
abuse
F15.182 dependence
F15.282 use
F15.982 cocaine
abuse
F14.182 dependence
F14.282 use
F14.982 drug NEC
abuse
F19.182 dependence
F19.282 use
F19.982 hypnotic
abuse
F13.182 dependence
F13.282 use
F13.982 opioid
abuse
F11.182 dependence
F11.282 use
F11.982 psychoactive substance NEC
abuse
F19.182 dependence
F19.282 use
F19.982 sedative
abuse
F13.182 dependence
F13.282 use
F13.982 stimulant NEC
abuse
F15.182 dependence
F15.282 use
F15.982 emotional
F51.9 excessive somnolence
--see Hypersomnia hypersomnia type
--see Hypersomnia initiating or maintaining
--see Insomnia nightmares
F51.5 nonorganic
F51.9 specified NEC
F51.8 parasomnia type
G47.50 specified NEC
G47.8 terrors
F51.4 walking
F51.3 sleep-wake pattern or schedule --see also Disorder, sleep, circadian rhythm
G47.9 specified NEC
G47.8 social
anxiety (of childhood)
F40.10 generalized
F40.11 functioning in childhood
F94.9 specified NEC
F94.8 pragmatic
F80.82 soft tissue
M79.9 ankle
M79.9 due to use, overuse and pressure
M70.90 ankle
M70.97- bursitis
--see Bursitis foot
M70.97- forearm
M70.93- hand
M70.94- lower leg
M70.96- multiple sites
M70.99 pelvic region
M70.95- shoulder region
M70.91- specified site NEC
M70.98 specified type NEC
M70.80 ankle
M70.87- foot
M70.87- forearm
M70.83- hand
M70.84- lower leg
M70.86- multiple sites
M70.89 pelvic region
M70.85- shoulder region
M70.81- specified site NEC
M70.88 thigh
M70.85- upper arm
M70.82- thigh
M70.95- upper arm
M70.92- foot
M79.9 forearm
M79.9 hand
M79.9 lower leg
M79.9 multiple sites
M79.9 occupational
--see Disorder, soft tissue, due to use, overuse and pressure pelvic region
M79.9 shoulder region
M79.9 specified type NEC
M79.89 thigh
M79.9 upper arm
M79.9 somatic symptom
F45.1 somatization
F45.0 somatoform
F45.9 pain (persistent)
F45.41 somatization (multiple) (long-lasting)
F45.0 specified NEC
F45.8 undifferentiated
F45.1 somnolence, excessive
--see Hypersomnia specific
arithmetical
F81.2 developmental, of motor
F82 reading
F81.0 speech and language
F80.9 spelling
F81.81 written expression
F81.81 speech
R47.9 articulation (functional) (specific)
F80.0 developmental
F80.9 specified NEC
R47.89 speech-sound
F80.0 spelling (specific)
F81.81 spine --see also Dorsopathy
ligamentous or muscular attachments, peripheral
--see Enthesopathy, spinal specified NEC
--see Dorsopathy, specified NEC stereotyped, habit or movement
F98.4 stimulant use (other) (unspecified)
mild
F15.10 in remission (early) (sustained)
F15.11 moderate or severe
F15.20 in remission (early) (sustained)
F15.21 stomach (functional)
--see Disorder, gastric stress
F43.9 acute
F43.0 post-traumatic
F43.10 acute
F43.11 chronic
F43.12 substance use (other) (unknown)
mild
F19.10 with substance-induced
anxiety disorder
F19.180 bipolar and related disorder
F19.14 depressive disorder
F19.14 major neurocognitive disorder
F19.17 mild neurocognitive disorder
F19.188 obsessive-compulsive and related disorder
F19.188 sexual dysfunction
F19.181 substance intoxication
F19.129 substance intoxication delirium
F19.121 moderate or severe
F19.20 with substance-induced
anxiety disorder
F19.280 bipolar and related disorder
F19.24 depressive disorder
F19.24 major neurocognitive disorder
F19.27 mild neurocognitive disorder
F19.288 obsessive-compulsive and related disorder
F19.288 sexual dysfunction
F19.281 in remission (early) (sustained)
F19.21 substance intoxication
F19.229 substance intoxication delirium
F19.221 sulfur-bearing amino-acid metabolism
E72.10 sweat gland (eccrine)
L74.9 apocrine
L75.9 specified NEC
L75.8 specified NEC
L74.8 synovium
M67.90 acromioclavicular
M67.91- ankle
M67.97- elbow
M67.92- foot
M67.97- forearm
M67.93- hand
M67.94- hip
M67.95- knee
M67.96- multiple sites
M67.99 rupture
--see Rupture, synovium shoulder
M67.91- specified type NEC
M67.80 acromioclavicular
M67.81- ankle
M67.87- elbow
M67.82- foot
M67.87- hand
M67.84- hip
M67.85- knee
M67.86- multiple sites
M67.89 wrist
M67.83- synovitis
--see Synovitis upper arm
M67.92- wrist
M67.93- temperature regulation, newborn
P81.9 specified NEC
P81.8 temporomandibular joint
M26.60- tendon
M67.90 acromioclavicular
M67.91- ankle
M67.97- contracture
--see Contracture, tendon elbow
M67.92- foot
M67.97- forearm
M67.93- hand
M67.94- hip
M67.95- knee
M67.96- multiple sites
M67.99 rupture
--see Rupture, tendon shoulder
M67.91- specified type NEC
M67.80 acromioclavicular
M67.81- ankle
M67.87- elbow
M67.82- foot
M67.87- hand
M67.84- hip
M67.85- knee
M67.86- multiple sites
M67.89 trunk
M67.88 wrist
M67.83- synovitis
--see Synovitis tendinitis
--see Tendinitis tenosynovitis
--see Tenosynovitis trunk
M67.98 upper arm
M67.92- wrist
M67.93- thoracic root NEC (nerve)
G54.3 thyrocalcitonin hypersecretion
E07.0 thyroid (gland)
E07.9 function NEC, neonatal, transitory
P72.2 iodine-deficiency related
E01.8 specified NEC
E07.89 tic
--see Tic tobacco use
chewing tobacco (mild) (moderate) (severe)
in remission (early) (sustained)
F17.221 cigarettes (mild) (moderate) (severe)
in remission (early) (sustained)
F17.211 mild
Z72.0 in remission (early) (sustained)
F17.201 moderate
F17.200 in remission (early) (sustained)
F17.201 severe
F17.200 in remission (early) (sustained)
F17.201 specified product NEC (mild) (moderate) (severe)
in remission (early) (sustained)
F17.291 tooth
K08.9 development
K00.9 specified NEC
K00.8 eruption
K00.6 Tourette's
F95.2 trance and possession
F44.89 transvestic
F65.1 trauma and stressor-related
F43.9 other specified
F43.8 tricuspid (valve)
--see Endocarditis, tricuspid tryptophan metabolism
E70.5 tubular, phosphate-losing
N25.0 tubulo-interstitial (in)
brucellosis
A23.9 [N16] cystinosis
E72.04 diphtheria
A36.84 glycogen storage disease
E74.00 [N16] leukemia NEC
C95.9- [N16] lymphoma NEC
C85.9- [N16] mixed cryoglobulinemia
D89.1 [N16] multiple myeloma
C90.0- [N16] Salmonella infection
A02.25 sarcoidosis
D86.84 sepsis
A41.9 [N16] streptococcal
A40.9 [N16] systemic lupus erythematosus
M32.15 toxoplasmosis
B58.83 transplant rejection
T86.91 [N16] Wilson's disease
E83.01 [N16] tubulo-renal function, impaired
N25.9 specified NEC
N25.89 tympanic membrane
H73.9- atrophy
--see Atrophy, tympanic membrane infection
--see Myringitis perforation
--see Perforation, tympanum specified NEC
H73.89- unsocialized aggressive
F91.1 urea cycle metabolism
E72.20 argininemia
E72.21 arginosuccinic aciduria
E72.22 citrullinemia
E72.23 ornithine transcarbamylase deficiency
E72.4 other specified
E72.29 ureter (in)
N28.9 schistosomiasis
B65.0 [N29] tuberculosis
A18.11 urethra
N36.9 specified NEC
N36.8 urinary system
N39.9 specified NEC
N39.8 valve, heart
aortic
--see Endocarditis, aortic mitral
--see Endocarditis, mitral pulmonary
--see Endocarditis, pulmonary rheumatic
aortic
--see Endocarditis, aortic, rheumatic mitral
--see Endocarditis, mitral pulmonary
--see Endocarditis, pulmonary, rheumatic tricuspid
--see Endocarditis, tricuspid tricuspid
--see Endocarditis, tricuspid vestibular function
H81.9- specified NEC --see subcategory H81.8
in diseases classified elsewhere
H82.- vertigo
--see Vertigo vision, binocular
H53.30 abnormal retinal correspondence
H53.31 diplopia
H53.2 fusion with defective stereopsis
H53.32 simultaneous perception
H53.33 suppression
H53.34 visual
cortex
blindness
H47.619 left brain
H47.612 right brain
H47.611 due to
inflammatory disorder
H47.629 left brain
H47.622 right brain
H47.621 neoplasm
H47.639 left brain
H47.632 right brain
H47.631 vascular disorder
H47.649 left brain
H47.642 right brain
H47.641 pathway
H47.9 due to
inflammatory disorder
H47.51- neoplasm
H47.52- vascular disorder
H47.53- optic chiasm
--see Disorder, optic, chiasm vitreous body
H43.9 crystalline deposits
--see Deposit, crystalline degeneration
--see Degeneration, vitreous hemorrhage
--see Hemorrhage, vitreous opacities
--see Opacity, vitreous prolapse
--see Prolapse, vitreous specified type NEC
H43.89 voice
R49.9 specified type NEC
R49.8 volatile solvent use
due to drug abuse
--see Abuse, drug, inhalant due to drug dependence
--see Dependence, drug, inhalant voyeuristic
F65.3 white blood cells
D72.9 specified NEC
D72.89 withdrawing, child or adolescent
F40.10